GSK to produce 1bn doses of coronavirus vaccine booster in 2021

World’s largest vaccine maker in talks with governments over manufacturing expansion

GlaxoSmithKline plans to produce 1bn doses of vaccine efficacy boosters, or adjuvants, next year for use in Covid-19 treatment.

The world’s largest vaccine maker said it was in talks with governments to back a manufacturing expansion that would help to scale up production of future vaccines for Covid-19.

Continue reading...